Citations

Clear

1098 citation(s) found for "Larson, K A".

Penicillin Allergy Delabeling in Children
Larson, Anthony S. , Lim, Peter Paul , Angal, Jyoti , Perry, Tamara T. , Blumenthal, Kimberly G.

Mayo Clinic

Pediatrics | November 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1542/peds.2026-077964 | PMID 42976931 Get It

Nearly 10% of the global population has been labeled as having a penicillin allergy. Of those labeled, about 95% are not truly allergic, yet most do not receive any allergy evaluations. Patients with penicillin allergy labels are more likely to have worse clinical outcomes and incur higher health care costs, largely because they do not receive penicillin and other first-line β-lactam antibiotics for the treatment of infectious diseases. Consequently, the process of evaluating and removing inaccurate penicillin allergy labels—a process known as “delabeling”—has become increasingly supported by a growing body of evidence. Recently, penicillin allergy has garnered substantial public interest with the proposal of federal legislation to include evaluation of penicillin allergy during routine medical visits for Medicare patients. Although this moves delabeling into the generalist purview, most of the emphasis on penicillin allergies and delabeling has been on adult patients. Yet, penicillin allergy is a pressing issue for pediatrics, as most penicillin allergy labels are placed in childhood. Pediatric literature similarly demonstrates negative clinical and public health consequences of inaccurate penicillin allergy labels. Recent guidelines have strongly recommended a proactive effort to identify and delabel inaccurate penicillin allergies in children. To facilitate this process, simple delabeling procedures, such as direct oral challenge with amoxicillin, have been recommended for patients with low-risk allergy status, based on historical reaction verification, because of their safety and accuracy. These advancements are relevant to practicing pediatricians across specialties and practice locations.
Added Value of Shear Wave Elastography for Noninvasive Detection of Axillary Lymph Node Metastasis and IHC-Defined Surrogate Subtype Characterization in Breast Cancer
Chen, Jie, Rosen, David , Parvar, Tanin Adl , Fazzio, Robert T. , Larson, Nicholas B. , Fatemi, Mostafa , Alizad, Azra

Mayo Clinic

Cancers | November 4, 2026 | Volume: 18 | Issue: 21 | Pages: 3549

10.3390/cancers18213549 Get It

Background: Accurate preoperative characterization of axillary lymph nodes (ALNs) is important in breast cancer, but conventional ultrasound has variable diagnostic performance. We evaluated quantitative shear wave elastography (SWE) for distinguishing reactive from metastatic ALNs, and we explored associations between nodal SWE parameters, breast cancer subtypes, and histological grades. Methods: We prospectively enrolled women with suspicious breast lesions and ALNs identified by clinical ultrasound who were scheduled for biopsy. After exclusions, 141 patients (57 reactive and 84 metastatic ALNs) were included. ElasticNet-regularized logistic regression with nested cross-validation compared clinical ultrasound alone with ultrasound plus SWE. Among 70 patients with metastatic ALNs and immunohistochemical characterization, SWE parameters were compared across surrogate subtypes and histological grades using Kruskal–Wallis tests with Holm adjustments. Results: The combined ultrasound–SWE model achieved an area under the receiver operating characteristic curve of 0.911 (95% CI, 0.859–0.961) compared to 0.798 (95% CI, 0.723–0.873) for ultrasound alone. At the Youden-derived threshold, the combined model achieved 88.1% sensitivity, 82.5% specificity, and 85.8% accuracy. Among metastatic ALNs, SWE parameters, namely Vmean, Vsd, and Vmax, differed significantly across surrogate subtypes, with the most pronounced differences observed between Luminal A and Luminal B tumors, (p = 0.0250, p = 0.0069, and p = 0.0065). No statistically significant differences were detected with histological grades in the five SWE parameters. Conclusions: Quantitative SWE complemented conventional ultrasound for assessing axillary nodal metastasis, with higher cross-validated discrimination for the combined model. Exploratory analyses identified differences in several SWE stiffness metrics between Luminal A and Luminal B tumors; these subtype-associated biomechanical differences require validation in larger cohorts.
Metaproteomic analysis of human sonicate fluid highlights neutrophil extracellular trap formation associated with periprosthetic joint infection
Garcia, Elijah , O'Connor, Kathleen , Koscianski, Christina A , Alvarez Otero, Judith , O'Donnell, Keara, Larson, Nicholas B , Pandey, Akhilesh , Holmes, David R , Patel, Robin

Mayo Clinic

Microbiology Spectrum | October 13, 2026 | Volume: 14 | Issue: 11 | Pages: No page available

10.1128/spectrum.00665-26 | PMID 42867249 Get It

ABSTRACT Periprosthetic joint infection (PJI) is a devastating complication of total joint arthroplasty that can be challenging to diagnose and treat. Neutrophils are a prominent feature in PJI, with neutrophil extracellular traps (NETs) known to be present; little is known, however, about the physiology of PJI-associated NETs. Here, the proteomes of PJI and non-infectious arthroplasty failure (NIAF), analyzed using liquid chromatography tandem mass-spectrometry (LC-MS/MS) and proximity extension assay (PEA)-based profiling of fluids derived from sonication of arthroplasty components removed from patients who had undergone revision arthroplasty, were compared, with a focus on NET formation. In addition, in vitro effects of synovial fluid components on Staphylococcus aureus- induced NET formation were characterized. LC-MS/MS (PJI n = 85, NIAF n = 26) and PEA (PJI n = 95, NIAF n = 39) showed NET formation and neutrophil degranulation to be associated with PJI, with the complement cascade and platelet activation pathways identified as potential contributors. In vitro studies showed delayed NET formation in artificial synovial fluid compared to standard cell culture media conventionally used to evaluate NETs. Together, these results demonstrate the presence of NETs in PJI, identify potential pathways involved in PJI-associated NETosis, and point to an influence of synovial components on NET formation during PJI. IMPORTANCE Periprosthetic joint infection (PJI) is a major complication of joint replacement, placing a significant burden on patients and the healthcare system. Our research reveals that neutrophils and their antimicrobial “traps” are dominant features of the immune response at the infection joint site. Importantly, we found that the unique environment of the joint delays the formation of these traps, potentially contributing to the pathogenesis of PJI. By establishing a new experimental platform tailored for the infected joint, this work provides a foundational platform for probing these mechanisms and supports the development of improved diagnostic and therapeutic strategies.
Intrathecal Hydromorphone Dosing for Adolescent Spinal Fusion: A Prospective Dose‐Escalation Study
Handlogten, Kathryn , Warner, Lindsay , Larson, A Noelle , Grigoriou, Emmanouil

Mayo Clinic

Pediatric Anesthesia | October 7, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/pan.70325 | PMID 42841453 Get It

ABSTRACT Background Intrathecal opioids are widely used for postoperative analgesia in pediatric spine surgery, but optimal dosing remains undefined. We evaluated the relationship between intrathecal hydromorphone (ITH) dose, analgesia, and adverse effects in adolescents undergoing posterior spinal fusion (PSF). Methods In this single‐center, prospective, blinded dose‐escalation study using a biased‐coin up‐down sequential allocation design, patients aged 10–17 years undergoing PSF received ITH starting at 3.5 mcg kg −1 , with dose adjustments based on analgesic response (range 2.0 to 7 mcg kg −1 with a maximum of 400 mcg). The primary outcome was maximum postoperative pain within 18 h. Secondary outcomes included pain burden (area under the curve), 24‐h systemic opioid consumption (oral morphine equivalents [OME], excluding ITH), adverse effects, supplemental diazepam use, and rescue opioid use. Associations between dose and outcomes were assessed using Spearman correlation and logistic regression. Results Twenty‐seven patients completed the study. The median ITH dose received was 5.5 mcg kg −1 (IQR, 3.5–7.0), with a median absolute dose of 370 mcg (IQR, 180–400). No significant association was observed between ITH dose and maximum pain ( r = 0.16, p = 0.41), pain burden ( r = 0.32, p = 0.10), or 24‐h OME ( r = 0.13, p = 0.52). ITH dose was not significantly associated with the time to rescue opioid (HR = 1.24; 95% CI 0.68–2.25; p = 0.485) or diazepam (HR = 1.10; 95% CI 0.72–1.71; p = 0.655). Adverse respiratory events occurred at doses > 5 mcg kg −1 without improved analgesia. Conclusions Increasing ITH dose was not associated with improved analgesia or change in supplemental opioid or diazepam use. Doses > 5 mcg kg −1 were associated with adverse respiratory effects. These findings support conservative dosing strategies and underscore the need to define the minimum effective dose in pediatric populations.
Peripheral oxygen extraction and central determinants of exercise capacity in adults with Fontan circulation
Van Belle, Hannah , Van De Bruaene, Alexander , Larson, Kathryn F. , Miranda, William R

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | September 25, 2026 | Volume: 331 | Issue: 6 | Pages: H2017-H2027

10.1152/ajpheart.00411.2026 | PMID 42788304 Get It

Peripheral impairment: a novel therapeutic target in Fontan physiology? Exercise intolerance is nearly universal in adults post-Fontan procedure. This exercise catheterization study showed that two-thirds of adults with Fontan circulation exhibited peripheral limitation to exercise, alongside established central hemodynamic constraints. Moreover, peripheral oxygen extraction was an independent determinant of exercise capacity in multivariable analyses. As demonstrated in HFpEF, peripheral oxygen extraction may represent a modifiable therapeutic target in Fontan physiology.
Maximal Aerobic Capacity Among Female Master Athletes: A Systematic Review And Meta-analysis
Larson, Kathryn F. , Collantes, Diana B., Morgan, Ashley M. , Pruter, Wyatt W. , Senefeld, Jonathon W. , Joyner, Michael J. , Kipp, Shalaya , Hoyos, Diana B. Collantes

Mayo Clinic

Medicine & Science in Sports & Exercise | September 18, 2026 | Volume: 58 | Issue: 10S | Pages: No page available

10.1249/01.mss.0001260100.88725.35 Get It

Why Open Surgery Must Live: Accompanying Laparoscopy to Its Death, A Reply to Kim et al
Violante, Tommaso , Sassun, Richard , Novelli, Marco , Larson, David W. , Rottoli, Matteo , Larson, David W , Violante, Tommaso , Sassun, Richard

Mayo Clinic

Annals of Surgery | September 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/sla.0000000000007224 | PMID 42717389 Get It

Performance of general-population breast cancer risk prediction models in an international consortium
Brantley, Kristen D. , Ahearn, Thomas U, Norton, Emily , MacInnis, Robert, Palmer, Julie R, Vachon, Celine M, Beane-Freeman, Laura, Frost, Reuben, Zirpoli, Gary, Neuhouser, Marian L, Barnett, Matthew, Teras, Lauren R, Patel, Alpa V, Bodelon, Clara, Spielfogel, Emma S. , Kirsh, Victoria A. , Langseth, Hilde , Milne, Roger L, Haiman, Christopher, Scott, Christopher G, Eliassen, A. Heather, Rosner, Bernard, Willett, Walter C, Chen, Yu, Wu, Fen , Zheng, Wei, Long, Jirong, O'Brien, Katie M, Sandler, Dale P, Linet, Martha S. , Anderson, Garnet, Larson, Joseph C. , Lee, I-Min, Chatterjee, Nilanjan, Kraft, Peter, Brantley, Kristen D , Kirsh, Victoria A , Ahearn, Thomas U. , Norton, Emily L., Palmer, Julie R. , Fortner, Renée T. , Vachon, Celine M. , González, Amy Berrington de , Bertrand, Kimberly A. , Zirpoli, Gary , Barnett, Matthew J , Teras, Lauren R. , Hodge, James M. , Patel, Alpa V , Bodelón, Clara , Lacey, James V. , Rohan, Thomas E. , Tsuruda, Kaitlyn M. , Milne, Roger L , Rosner, Bernard, Willett, Walter C. , Romanos-Nanclares, Andrea , Zheng, Wei , Long, Jirong, O’Brien, Katie M. , Sandler, Dale P. , Kitahara, Cari M. , Anderson, Garnet L. , Lee, I-Min, García‐Closas, Montserrat , Chatterjee, Nilanjan

Mayo Clinic

No container title available | August 24, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.08.20.26360899 Get It

Background: Several breast cancer (BC) risk prediction models have been developed to provide personal risk assessments. Though individually validated, their performance has not been systematically evaluated across a wide range of populations or ages. Methods: We harmonized individual-level baseline questionnaire data and incident BC diagnoses from 21 cohorts from North America, Europe, and Australia participating in the Breast Cancer Risk Prediction Project. Five-year absolute risk of invasive BC was estimated for five established risk prediction models using classical risk factors only. Discrimination was evaluated by area under the curve (AUC). Calibration was assessed using average and risk-decile specific expected to observed (E/O) ratios. Performance metrics were meta-analyzed across cohorts and models. Metaregression tested associations between cohort characteristics and performance metrics. Results: This analysis included 1,595,977 women aged 20-75 years, enrolled in studies between 1976-2015, with 19,062 (1.2%) invasive BC cases ascertained within 5 years from exposure assessment. Age-adjusted AUCs were similar across models and cohorts (pooled AUCs by model: 0.57-0.58), while E/O ratios varied substantially (pooled E/O ratios by model: 0.83-1.25). Overestimation was common among predicted high-risk individuals (>3%). No appreciable differences in model performance by cohort age, birth year, race, and variable missingness emerged. Calibration improved after assigning race-specific incidence rates. Conclusion: Existing BC risk prediction models provided similar risk discrimination across multiple cohorts, although there was overestimation of risk for high-risk individuals. Performance variation across cohorts was not driven by specific characteristics, which supports development of a unified risk model for diverse populations that leverages appropriate incidence rates.
OA08.2. Impact of GLP1 Receptor Agonists on Progression of Non Dysplastic Barrett’s Esophagus: A Large Propensity Matched Cohort Study
Mann, Russaal Singh, Sachdeva, Karan, Dhaliwal, Lovekirat , Larson, Stefanie, Iyer, Prasad G. , Sachdeva, Karan

Mayo Clinic

Diseases of the Esophagus | August 22, 2026 | Volume: 39 | Issue: Supplement_1 | Pages: No page available

10.1093/dote/doag077.054 Get It

Abstract Topic Esophageal Cancer: Barrett‘s Esophagus: High-Grade Dysplasia and Early Invasive Cancer Background Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) delay gastric emptying and are linked to increased gastroesophageal reflux, a recognized risk factor for Barrett’s esophagus (BE) progression to esophageal cancer (EC). Extended use of GLP-1 RAs facilitates weight loss, mitigating reflux, possibly offering a protective effect against EC. This large retrospective study aimed to assess the association between GLP-1 use with the development of dysplastic Barrett’s esophagus (BE) and EC in patients with non-dysplastic BE (NDBE). Methods We used ICD and CPT codes within the TriNetX (a large multicenter claims based) database to identify NDBE patients. The cohort was then categorized as GLP-1 users vs. non-users based on ATC code A10BJ. A 1:1 propensity matched analysis was performed with balancing of confounders (Table 1). Primary outcomes included incidence of dysplastic BE and EC. Time to event analyses were performed. Results A total of 4,534 patients were identified in the GLP-1 cohort and 55,621 in the non-GLP-1 cohort. After 1:1 matching, 4,530 patients were included in each cohort. Mean follow-up was 3.57 years in GLP-1 cohort and 3.30 years in non-GLP-1 cohort. Incidence of dysplastic BE/EC in the GLP 1 cohort was 1.24% (N=56) compared to 0.54% (N=24) in non-GLP 1 cohort. GLP-1 users demonstrated significantly higher risk of developing dysplastic BE/EC compared to non-users (RR: 2.30; 95% CI: 1.47–3.70, P = 0.0004. The cumulative incidence of dysplastic BE/EC was higher among GLP-1 cohort at 3 and 5 years—0.90 %, and 1.11%, respectively—compared to 0.47%, and 0.49 % in the non-GLP-1 group. Conclusion Our findings indicate that GLP-1 therapy was associated with an increased risk of progression to dysplastic BE/EC in patients with non-dysplastic BE. Further prospective studies are warranted to validate these results.
Perinatal and Early-Life Exposures and Risk of Non-Hodgkin Lymphoma
Cholack, George , Kleinstern, Geffen , Robinson, Dennis P. , Thompson, Carrie A. , Call, Timothy G. , Feldman, Andrew L. , Larson, Melissa C. , Mwangi, Raphael , Ansell, Stephen M. , Novak, Anne J. , Kay, Neil E. , Slager, Susan L. , Cerhan, James R. , Cholack, George A , Habermann, Thomas , Cozen, Wendy , Slager, Susan L , Cerhan, James R , Feldman, Andrew L , Kay, Neil E , Ansell, Stephen M , Novak, Anne J , Call, Timothy G , Larson, Melissa C , Habermann, Thomas M. , Cozen, Wendy

Mayo Clinic

Cancers | August 18, 2026 | Volume: 18 | Issue: 16 | Pages: 2666

10.3390/cancers18162666 | PMID 42649977 Get It

Background: Perinatal and early-life factors may influence non-Hodgkin lymphoma (NHL) risk, but study results have been mixed and exposure data for childhood ages are limited. Herein, we investigated associations of these exposures with risk of NHL and common subtypes. Methods: This case–control study included 2280 NHL cases and 2253 controls, enrolled from 2002 to 2014 at the Mayo Clinic Rochester. Self-reported perinatal and early-life exposures included maternal age at birth, birth order, birthweight, time breastfed, height and weight at ages 7, 12, and 18 years relative to peers, and age and weight when growth ceased. We used logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for design variables and potential confounders. Linear trend tests were performed for ordinal variables, and heterogeneity tests were performed to evaluate whether associations varied across four NHL subtypes. Results: After multivariable adjustment, greater birth weight (OR = 1.15 for quartile 4 vs. 1; p-trend = 0.04), weight at age 7 relative to peers (compared to average, OR = 1.05 for heavy and OR = 0.87 for thin; p-trend = 0.002), and weight when growth ceased (OR = 1.30 for quartile 4 vs. 1; p-trend < 0.001) were associated with increased NHL risk. An inverse association was observed for breastfeeding duration with NHL risk (OR = 0.77 for >6 months vs. never; 95% CI 0.61–0.97). Associations did not significantly vary by major NHL subtype (p-heterogeneity > 0.05). Other perinatal and early-life exposures were not associated with NHL risk. Conclusions: Greater body weight at birth and through childhood may be associated with increased NHL risk, potentially extending the life-course perspective on adiposity and lymphomagenesis, with implications for prevention.